Articaine HCl Powder,The chemical name is 4-methyl-3- [[1-oxo-2- (propylamino) propyl] amino] -2-thiophenecarboxylic acid methyl ester hydrochloride, which is a white or off white crystalline powder. Its CAS number is 23964-57-0, molecular formula is C13H20N2O3S · ClH, and molecular weight is approximately 320.84. It has stable chemical properties, but may undergo changes under specific conditions. For example, in high temperature or humid environments, its stability may be affected. Therefore, strict control of temperature and humidity conditions is necessary during storage and use to ensure the stability and effectiveness of the drug. At the same time, it also has some other pharmacological properties. For example, it can be metabolized by esterases in the blood and tissues, thereby avoiding accumulation in the body. This metabolic characteristic results in lower toxicity and side effects of articaine hydrochloride powder during use. In the field of dentistry, the use of articaine hydrochloride has some unique advantages. For example, it has a fast onset time and usually produces anesthetic effects within a few minutes after administration; Moderate duration, able to meet the needs of most oral surgeries; The tissue has strong infiltrative properties and can complete surgical procedures such as tooth extraction, tooth preparation, and pulp treatment for upper and lower posterior teeth through conventional submucosal infiltration methods.
We provide Articaine Hcl powder, please refer to the following website for detailed specifications and product information.
What is Articaine Hcl powder 4% and epinephrine?
It is a powdered drug containing Articaine HCl Powder, which is an efficient and safe local anesthetic widely used in dental and oral surgery. It is odorless and easily soluble in water. As an amide local anesthetic, its main pharmacological effect is to block nerve conduction, thereby achieving anesthetic effects. Specifically, it can selectively act on sodium ion channels on the membrane of nerve cells, preventing the influx of sodium ions and thereby inhibiting the generation and transmission of nerve impulses. This mechanism of action makes 4% articaine HCl powder significantly effective in local anesthesia. It can be metabolized by esterases in the blood and tissues, thus avoiding accumulation in the body. This metabolic characteristic results in low toxicity and side effects of 4% articaine HCl powder during use. At the same time, it also has good tissue infiltration and penetration, which can quickly reach the anesthesia site and exert its therapeutic effect. Due to its being a common dental local anesthetic, it has broad application prospects in the market. With the continuous development of dentistry and people's increasing attention to oral health, the demand for 4% articaine HCl is also constantly increasing. In addition, with the continuous advancement of medical technology and the increasing demand for medical safety, the production and quality control standards of 4% articaine HCl are also constantly improving. This helps ensure the safety and effectiveness of drugs, providing better medical services for patients.
Epinephrine
Adrenaline is an important hormone secreted by the human adrenal medulla and also a neurotransmitter. It plays a crucial role in the human body, especially when dealing with stimuli such as stress, tension, or fear. The secretion of adrenaline significantly increases, triggering a series of physiological reactions that help the body cope with these challenges. At the same time, it is also an amine compound with alpha and beta receptor agonists, which is easily soluble in water at room temperature and has strong vasoconstrictive and myocardial excitatory effects. It interacts with receptors on the cell membrane, leading to activation of intracellular signaling pathways and subsequently affecting the functions of organs such as the cardiovascular and respiratory systems. Although the content of adrenaline in the human body is slightly low, its effect is very powerful and it is an essential substance for maintaining normal physiological functions in the human body. Its biosynthesis is a complex process that mainly occurs in various cells of the adrenal medulla. Firstly, cells will form norepinephrine, which is a precursor substance of adrenaline. Then, under the action of phenylethanolamine N-methyltransferase (PNMT), norepinephrine will be further methylated to form adrenaline. This process ensures a continuous supply of adrenaline in the human body to address various physiological and pathological challenges.
What are the interactions between this compound and other drugs?
Interaction with cardiovascular drugs
The adrenaline component in the articaine HCl powder may interact with guanidine drugs such as guanidine and levothyroxine. Guanethidine drugs have anti adrenergic effects and may weaken the vasoconstrictive effect caused by adrenaline. This interaction may reduce the anesthetic effect of 4% articaine HCl and increase the risk of bleeding during surgery. Therefore, when using 4% articaine HCl, it should be avoided to use it together with guanidine drugs. It may also interact with other cardiovascular drugs such as beta blockers, calcium channel blockers, etc., affecting heart function and blood pressure. These interactions may lead to adverse reactions such as abnormal heart function and blood pressure fluctuations. Therefore, when using 4% articaine HCl, the patient's cardiovascular condition should be carefully evaluated and individualized adjustments should be made based on the need for cardiovascular medication.
Interaction with central nervous system drugs
The adrenaline component in 4% articaine HCl may interact with certain antidepressants such as tricyclic antidepressants, monoamine oxidase inhibitors, etc. These antidepressants may increase the stimulating effect of adrenaline on the central nervous system, leading to adverse reactions such as overexcitement and anxiety. When using, the central nervous system condition of patients should be carefully evaluated, especially for those with a history of mental illness or who are currently using antidepressants. When necessary, it may be necessary to adjust the dosage of antidepressants or choose other anesthetics.Adrenaline may interact with sedative hypnotic drugs (such as benzodiazepines), affecting the patient's consciousness and sleep state. This interaction may lead to adverse reactions such as blurred consciousness, drowsiness, or respiratory depression in patients. Therefore, when using 4% articaine HCl, the patient's use of sedatives and hypnotics should be carefully evaluated, and the drug dosage should be adjusted or other anesthesia methods should be chosen as needed.
Interaction with respiratory system drugs
Adrenaline has a relaxing effect on bronchial smooth muscle, which may be enhanced when combined with bronchodilators such as β 2 receptor agonists and theophylline drugs. However, in some cases, this interaction may lead to excessive relaxation of bronchial smooth muscle, causing adverse reactions such as breathing difficulties or hypoxemia. When using 4% articaine HCl, the respiratory condition of patients should be carefully evaluated, especially for those with respiratory diseases such as asthma or chronic obstructive pulmonary disease. When necessary, it may be necessary to adjust the dosage of bronchodilators or choose other anesthesia methods. When adrenaline is combined with anticholinergic drugs (such as atropine, scopolamine, etc.), they may antagonize each other's effects. Anticholinergic drugs can inhibit the excitatory effect of cholinergic nerves, while adrenaline produces excitatory effects by activating adrenergic nerves. This antagonistic effect may lead to a decrease in anesthesia effectiveness or an increase in adverse reactions. When using 4% articaine HCl powder, the patient's use of anticholinergic drugs should be carefully evaluated, and the drug dosage should be adjusted or other anesthesia methods selected as needed.
Interaction with metabolic drugs
Adrenaline has the effect of raising blood sugar, and when used in combination with hypoglycemic drugs such as insulin and sulfonylureas, it may weaken the effectiveness of hypoglycemic drugs. This interaction may lead to adverse reactions such as blood glucose fluctuations or hypoglycemic reactions. Therefore, when using articaine HCl powder, the patient's medical history of diabetes and the use of hypoglycemic drugs should be carefully evaluated, and the dosage of hypoglycemic drugs should be adjusted or other anesthesia methods should be selected as needed. Non selective monoamine oxidase inhibitors (such as isocarbohydrazide, selenide, etc.) may inhibit the metabolic process of adrenaline in the body, leading to the accumulation of adrenaline in the body and causing toxic reactions. This interaction may lead to serious adverse reactions such as hypertensive crisis and arrhythmia. Therefore, when using 4% articaine HCl, it should be avoided to use it together with non selective monoamine oxidase inhibitors.